Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-054452
Filing Date
2007-03-14
Accepted
2007-03-14 14:55:18
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1261688
2 AMENDMENT AGREEMENT DATED DECEMBER 14, 2006 dex108j.htm EX-10.8J 28665
3 SEPARATION AGREEMENT DATED NOVEMBER 10, 2006 dex1025.htm EX-10.25 27103
4 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES dex121.htm EX-12.1 24125
5 LIST OF SUBSIDIARIES dex211.htm EX-21.1 4863
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2500
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9111
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9082
9 CERTIFICATION OF ANNUAL FINANCIAL REPORT BY THE CHIEF OFFICERS dex32.htm EX-32 4631
  Complete submission text file 0001193125-07-054452.txt   1373086
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 07693379
SIC: 2836 Biological Products, (No Diagnostic Substances)